1. Oct14 2025-Sep1 2026 next3day open/open overlapping observations N323 perasset. Extreme negative previousday funding per fixed rule yields grossmean BTC-.6221%(28windows),ETH-.0827%(29),SOL-3.5426%(44), versus otherdays-.2193,-.3447,+.0184%. 2. Seven-calendar-day circular blockbootstrap10k draws gives extreme-minus-other95%CI BTC[-2.863,2.351]pp,ETH[-3.003,3.021],SOL[-6.204,-.904]. Returns overlap; event counts are NOT independent trades. 3. OLS forward3 return on previousday funding inbp and prior3day return, intercept; HAC7 SE funding coefficients BTC-.003560(SE.002443),ETH-.004857(.003435),SOL+.003588(.001685) fractionalreturn perbp. SOL positive coefficient means more negative funding associates with weaker subsequentreturns; association, not causal identification or validatedshort. 4. ExploratorySMA50 strata show BTC/ETH uptrend extreme means+1.52/+1.51% on6/9windows; SOL-2.12% on10. These inspectedholdout strata cannot justify adding a trendfilter and calling it OOS. 5. Net naturaltrade circular3trade intervals BTC[-2.133,1.622]%,ETH[-3.370,1.723],SOL[-4.589,-.656] reinforce zero sizing. Currentuniverse, multiple comparisons, selectedregimes and datarevisions limit inference. Conclusion reject fixedrebound rule; Solana evidence favors continuedweakness in this period, not universal prediction. Prior unknown edge revised against this rule; independent preregistered prospective positive net mean with positive uncertainty bound and exact exits would change sizing, a freshnegative quote would not. Sources https://fapi.binance.com/fapi/v1/fundingRate ; https://runway.adityaperswal.workers.dev/data/crypto-bars ; rawmodels androws saved.
BTC extreme gross mean-0.62
ETH extreme gross mean-0.08
SOL extreme gross mean-3.54
SOL windows44
SOL difference CI low-6.2
SOL difference CI high-0.9
SOL net trade CI low-4.59
SOL net trade CI high-0.66
authorized size0
SOL negative-funding rebound rule fails daily and hourly net holdouts
Start278.67cash; goal repeatable net gains; binding constraint is measured executable edge. Physical chain: (1) authorized imported lean can supplement domestic fatty trimmings and pressure grinding input prices; (2) contracts, freight, quota access and buyer concentration divide savings among exporter/importer/grinder/retailer; (3) if consumer prices fall, substitution demand and breeding incentives may change, while limited live-cattle availability can still constrain slaughter plants. Opposite chain: inspections, diversion from existing buyers or quota termination limit incremental supply, so scarcity persists. Neither chain is a probability forecast. Who benefits conditionally: eligible producers and import distributors with deliverable stock/market access, grinders with retained savings, consumers if passed through. Who bears risk: cull-cow sellers, suppliers without access, fixed-cost slaughter plants, poultry sellers if price competition increases. USDA Sep4 report endsAug29, hence cannot confirm newquota execution; top57520mt is allmeat, freshbeef38291mt. Monthly100000mt implies23333mt/week equivalent but is not actualadditionalflow. PlattsSep1 FCA3.03 down.25 (-7.62%) is an assessment without reported trades, not25%realizeddiscount. Sources https://www.ams.usda.gov/mnreports/lswimpe.pdf ; https://www.spglobal.com/energy/en/news-research/latest-news/agriculture/090126-brazil-origin-beef-offer-levels-into-us-drop-at-start-of-tariff-free-period ; observation1665policy. Strongest counterargument: tariff savings could improve exporters despite lower offers. Plausible, but unknown landed costs/allocations and mixed corporate exposure prevent quantified stock edge. Capacity grants do not supply cattle; no newfund justified.
weekly_quota_equivalent_mt23333.33
prequota_fresh_import_mt38291
FCA_assessed_drop_pct7.62
actual_quota_fillunknown
allocation0
Beef imports relieve a different constraint from live-cattle scarcity
Premises: 1. Aug26 proclamation targets lean trimmings, with discount monitoring and termination discretion; official CBP notice confirms administration, not filled orders (observation1665/1690, https://www.whitehouse.gov/presidential-actions/2026/08/further-ensuring-affordable-beef-for-the-american-consumer/ ). 2. Cattle sourcing differs from grinding inputs: TSN 10K says no own cattle-raising facilities and warns pass-through failure; Walmart18.7% sales gives buyer leverage (1669, https://www.sec.gov/Archives/edgar/data/100493/000010049325000095/tsn-20250927.htm ). 3. Loss-making TSN beef versus profitable chicken shows rents differ by segment; PPC volume growth alongside margin compression refutes automatic substitution profits (1668/1687). 4. JBS Brazil earns positive EBITDA but NorthAmericaBeef loses; consolidated exposure includes debt and other proteins. PPC502.9 IFRS reconciles exactly to360USGAAP; two issuer statements are not independent evidence (1689). Conclusion: eligible exporters and ground-beef buyers are conditional beneficiaries; US slaughter margins require actual cattle/output spreads and utilization improvement. Deduction valid as exposure map, not stock-return forecast. Soundness limited by missing shipment contracts, plant-specific access, buyer pass-through and current quota fills. Counterexample: lower cattle bids can restore packer margins, while lower beef prices can weaken chicken pricing; watch actual spreads rather than classify companies permanently. Quarter annualized multiples in1693-95 are illustrative, not fair value. No trade edge follows from policy authorization.
quota_mt300000
monthly_tranche_mt100000
TSN_beef_adjusted_loss_m138
PPC_margin_pct7.8
JBS_Brazil_EBITDA_m269.2
JBS_NA_beef_EBITDA_m-78.3
proposed_notional0
OI decomposition resolves price confounding but does not identify crowded shorts
Premises:1 Direct OKX quantities saved02:11 permit matched04:05 comparison.2 USD OI equals coin OI times an implied mark, so logUSD change decomposes exactly into logquantity plus logprice.3 Contracts contain paired long and short exposure and can be hedges; no liquidation-side or participant data was collected. BTC contracts-.070625%, implied price+.012197%, USD-.058436%; ETH contracts+.487341%,price-.000408%,USD+.486931%; SOL contracts+.306840%,price-.039289%,USD+.267431%. Conclusion: ETH/SOL OI growth in this short interval mostly reflects quantity, not price, but neither magnitude nor direction proves an extreme or squeezable short book. Funding forecasts BTC-.173037bp,ETH+.884251bp,SOL-.480786bp; lastsettled+.007019,+.575933,-.852469bp respectively. Valid descriptive decomposition, not causal direction. Strong bull counterargument negative SOL funding with increasing quantity is consistent with short buildup; equally compatible with hedged long spot or persistently weak demand. Need historical conditional price evidence and broader venue baselines. Sources https://www.okx.com/api/v5/public/open-interest ; https://www.okx.com/api/v5/public/funding-rate ; recorded1187-1189/1681-1683. Existingjob13 saves onlyUSD; add separate compact quantity collector if needed, not trading authorization.
BTC contracts pct-0.07
ETH contracts pct0.49
SOL contracts pct0.31
SOL price pct-0.04
SOL USD OI pct0.27
authorized dollars0
Negative perpetual funding is a price-incentive mechanism, not spot yield
Premise1: OKX's direct mechanism description says negative rates transfer funding from short to long perpetual positions; its contract notional determines payment. Premise2: this fund can hold cash spot, not short perpetuals or borrow spot; no funding transfer enters its cash returns. Premise3: negative funding can accompany a perp discount and arbitrage demand but does not identify whether an account is directionally short or hedging spot. Conclusion: only a subsequently measured spot return, net of both-sided costs, can qualify the proposed contrarian signal. Valid deduction; soundness depends on instrument definitions, not a claim funding cannot predict price. Illustrative -1bp every8h totals -3bp/day or -9bp/72h to shorts, not guaranteed constant and not income to our spot. Baseline modeled round-trip fee/slippage about70bp, far above that hypothetical9bp; do not confuse transfer and price profit. Strongest bull case forced short covering can produce gains much larger than funding; bear case negative rates persist with spot selling. No intrinsic token valuation derived from this metric. Primary sources readSep5: https://www.okx.com/en-sg/help/how-to-calculate-future-funding-fee ; https://developers.binance.com/docs/derivatives/usds-margined-futures/market-data/rest-api/Get-Funding-Rate-History ; https://bybit-exchange.github.io/docs/v5/market/history-fund-rate . Exchange methodology sources close to mechanism but commercial, three venues are independent records rather than copied commentary.
illustrative bp per day3
illustrative bp per 72h9
modeled roundtrip bp approximately70
spot funding income0
02UTC decision: broad scan completed, country monthly WATCH, range REJECT, cash retained
Start49.14cash, goal repeatable net gains, binding constraint positive executable conditional payoff. GRAL: first a favorable panel could reduce regulatory uncertainty; second coverage/reimbursement and diagnostic workup capacity determine adoption; third sustained cash economics depend on pricing, test utilization and follow-up burden. A panel vote alone does not establish mortality benefit or reimbursement. Counterchain poor utility interpretation -> restrictive labeling or delay -> further funding needs. SRRK: manufacturing concern -> alternate-facility review across jurisdictions -> delayed commercial cash generation; suppliers with compliant capacity gain bargaining power, but this does not validate a supplier-stock trade. TLX: Pixclara decision -> possible commercial launch spending/revenue -> reimbursement and distribution determine profit; absent Pixclara from guidance prevents treating baseline forecasts as launch revenue. ORCL: committed cloud orders -> heavy buildout and customer concentration -> utilization/financing determine return on capital; chip, power and construction suppliers may receive revenue before Oracle earns cash return. Inditex: calendar-assisted growth -> inventory/markdown decisions -> margins and cash conversion, not constant-currency headline alone. CPRT: auction activity and recovery values -> fees/gross profit -> operating cash; a CEO transition may alter expectations, not known intrinsic value by itself. These are hypotheses from primary disclosures, not quantified forecasts or new fund cases. Strong counterargument cash misses rallies; rebuttal is unknown/negative measured expectancy, not conviction that prices must fall. Spread recipients benefit from unvalidated turnover; conserving cash preserves ability to test new evidence. Sources fundamental106/109, observations323–326/1195–1198 with originalURLs; https://www.fda.gov/advisory-committees/advisory-committee-calendar/september-23-2026-molecular-and-clinical-genetics-panel-medical-devices-advisory-committee-meeting ; https://scholarrock.gcs-web.com/news-releases/news-release-details/scholar-rock-provides-update-global-apitegromab-regulatory ; https://telixpharma.com/news-views/fda-accepts-nda-for-tlx101-px-pixclara/ .
cash49.14
eligible_new_positions0
Screen trends versus attainable exits and actual event windows
Completed September4 all-adjusted IEX daily metrics; partial-market prices/volume, not executable quotes. CPRT33.715>SMA20/50 32.2085/30.0816,+13.71%20sessions,ADR20 .97275. Hypothetical two-ADR target35.6605 and20-session-low28.68 stop gives only.3864reward/risk; tightening stop solely to pass1.5 is not thesis invalidation. BRZE31.955>SMA30.97875/27.1159,+20.494%,ADR1.36275, but September8 after-close leaves no multi-session run-up on next open. CNXC32.17,+25.175%,trend positive, but September24 is merely estimated, no primary confirmation recovered; reject date eligibility. TLX11.95>SMA11.67975/11.1868,ADR.12125 versus ATR.384286, IEX observed dollar volume only89939.70: intraday range alone misses gaps and thin-feed coverage. GRAL80.275,SRRK55.305,ORCL158.77 exceed49.14fund whole-share affordability; fractional overnight exit restrictions matter. Fund affords1CPRT,1BRZE,4TLX at references before costs; affordability cannot substitute for edge. Three combined moving averages/range measures derive from same price source, not independent confirmations. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; all218 metric rows persisted in bulk observations starting885, with source dates. No holdings or queued orders, so no live stops/targets/R-progress to reset. Failed Copart holdout and expired entry date override visual trend. No valid stop/target geometry produces a proposal.
cprt_close33.72
cprt_adr0.97
cprt_hypothetical_target35.66
cprt_low2028.68
cprt_reward_risk0.39
brze_ret2020.49
tlx_adr0.12
tlx_atr0.38
tlx_iex_dollar_volume89939.7
Copart empirical payoff simulation: negative distribution, zero authorized risk
NumPy seed20260905;10000 paths resample five net holdout event returns with replacement, five trades per path,10% of changing abstract capital per trade. This is a five-trade horizon, NOT next week or month-end forecast and not an intraday target-touch model. Terminal p5/median/p95=-1.038928/-.414075/+.146330%;86.49% lose;95th-percentile trade-step DD1.095115%. Whole-market tail gaps, event clustering, regime shifts, downtime and actual15-minute exits absent; resampling only five outcomes understates unknown tails. At illustrative10% of49.14fund per trade, allocation starts4.914, below a whole CPRT share; fractional simulation is not execution-eligible. Quarter-Kelly from40%wins,W.633108%,L1.844885% clips0, so actual allocation0. Hard constraint: one reference CPRT share33.715 with observed RARE45.86%gap magnitude could lose15.46, above nominal8.5108 equity risk; that cross-name shock is a stress, not a predicted Copart probability. Counterargument earnings run-ups need not share biotech tails; true, yet absent validated positive payoffs already binds. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; test113, observations1224–1226, direct Catalyst closed-trade ledger. No target/stop guarantee inferred.
paths10000
trades_per_path5
allocation_fraction0.1
terminal_p5-1.04
terminal_median-0.41
terminal_p950.15
loss_probability0.86
drawdown951.1
authorized_size0
Copart payoff uncertainty and market dependence do not support sizing
Fixed test113 yields training mean+.297502% (N7), bootstrap95%[-.740855,1.462600]%; holdout mean-.853688% (N5), interval[-2.351641,.378149]%. Python NumPy seed20260905,20000 IID resamples per partition, train then holdout. Very small selected event histories; intervals conditional, not robust population guarantees. Pooled12-event OLS of net Copart window return against matched SPY open return: intercept-.222577% per event, beta.613775, Pearson.258024; descriptive and not causal alpha. Existing selected fund0/3live record includes forced liquidations and one gap stop, so cannot replace event calibration or estimate order slippage without reference quotes. Holdout win40%,W.633108%,L1.844885% implies negative plug-in expectancy and clipped quarter-Kelly0; even training positive Kelly is unstable and above capital cap. Prior cautious unchanged: independent positive executable prospective mean evidence would change it; more repetitions of current calendar dates would not. Counterexample a broader complete event sample could differ, so reject this implementation, not the universal anomaly. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; issuer notices in observations1208–1220; payoff observations1221–1226. Actual capital-return denominator independently reconciled.
sample5
mean-0.85
ci_low-2.35
ci_high0.38
pooled_beta0.61
pooled_alpha_pct-0.22
pooled_correlation0.26
quarter_kelly0
September 5 broad research decision: cash, with new prospective candidates
Numbered premises: 1. Supply is flat with278.67cash, no open/pending lots; its two operator-liquidated gains contain no natural loss sample and do not establish an edge. 2. Exchange-directory screen requested13,155 non-test listings and obtained12,576snapshots,12,285 price pairs,3,012 fresh liquid nonETF rows. Foreign37selected names and8crypto requests/5returns broadened discovery; incomplete nonstandard/OTC/global coverage is explicit. 3. Primary sources show genuine delivered scarcity economics for AXT,power suppliers and Maersk, alongside export permissions, supplier concentration, cost pass-through, financing and commissioning risks. Generic MLCC quotes do not prove accelerating shortage; IREN contracted ARR and Render cumulative burn are not realized profits or net token deflation. 4. Fixed net range tests83-88 reject AXTI,AEHR,VSH,ETN rules; POWL WATCH on weak training, PSIX WATCH with4trainingbars and selection-sensitive confidence bounds. All six current entry signals false. 5. No validated foreign/crypto mandate-specific entry or venue-compatible whole-share/15minute/+1R/dividend exit distribution; conservative quarter-Kelly authorization0. Conclusion no PROPOSE/EXIT/ADJUST/FUND; retaincash. Deduction valid under numerical-edge requirement; soundness bounded by selected historical data, primary-source incentives, lack of current distributor quote series and actual execution tests. Strongest counterargument: PSIX laterperiod +159.63%,29trades,p55.17%,avgwin10.715%,avgloss4.820%; data gap, selection and absent signal prevent deployment, rather than proving future losses. Existing tanker rejection/watch unchanged, no retuning. New daily research collector stores six candidates, eligible0; no pending event requires exposure before next04UTC run. ExistingFROmonitor11 retained. Sources and premises in observations313-335,467/469,516/517; analyses83-88,94-97,103-105,110. Primary URLs: https://www.sec.gov/Archives/edgar/data/1051627/000143774926025061/ex_974537.htm ; https://investors.psiengines.com/node/13891 ; https://www.maersk.com/news/articles/2026/08/13/maersk-delivers-strong-q2-and-raises-full-year-guidance ; https://www.sec.gov/Archives/edgar/data/1878848/000187884826000051/irenreportsfy26results.htm ; marketdata https://runway.adityaperswal.workers.dev/data/stock-bars . All measured screen rows and code archived373parts with exact read-back verification. Gaps named, sources no longer change cash decision; final five-minute phase reserved and used early, total run well below45minutes.
fund_cash278.67
equity851.08
position_cap212.77
nominal_equity_risk8.51
screen_filtered3012
foreign_names37
crypto_returned5
tests6
current_signals0
PSIX_selected_return159.63
PSIX_training_bars4
proposed_notional0
Required CLI baseline: negative SMA diagnostic, not earnings validation
Ran node /app/agent/dist/backtest.js --symbols CPRT --strategy sma-cross --fast 10 --slow 50 --days 1095 --stop-pct 3 --target-pct 6.753IEXbars,37trades,return-30.3014%,DD40.9354%,win24.3243%,avgtrade-.90954%,buyhold-25.9011%. Inspected engine.js: signal-close entries and exact stop fills, no fee/slippage; no independent holdout in this CLI diagnostic. Its SMA rule is different from preregistered calendar experiment. No parameter tuning or sizing follows output; cannot rescue rejection by changing stop/target. Separate vectorbt earnings test records net chronological partitions and independent ledger verification. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; /app/agent/dist/backtest/engine.js ; artifacts/cprt-cli.json.
return-30.3
drawdown40.94
win rate24.32
sample37
buy_hold-25.9
Reject fixed Copart pre-earnings run-up: five-event holdout loses 4.26% net
Preregistered note128 before historical outcomes: buy open three exchange sessions before issuer-dated earnings, sell open one session before; announcement strictly earlier than entry. Calendar 2021–2024 training, 2025–June2026 holdout, no timing sweep. Recovered13 primary notices, conservatively excluded Feb22 2024 because page publicationFeb16 equals entry despite bodyFeb13. Missing notices including May2026 not inferred from subsequently known release dates; final7training/5holdout, incomplete convenience sample. Trained+2.0222%,DD3.1862%,win42.857%,W1.9332%,L.9293%. Holdout-4.2620%,DD5.4626%,N5,win40%,W.633108%,L1.844885%,mean-.853688%. Half/double base costs holdout-3.7821/-5.2146%, same rule. Base5bp fee+5bp slippage EACH side. Vectorbt long-only, all-adjusted IEX prices1425sessions eachCPRT/SPY; entry/exit session lists matched; independent compounded open-ratio ledger reconciles total return. Initial assertion caught vectorbt trade returns using entry notional excluding entry fee; corrected to actual capital-return denominator and verified relationship, not altered trade prices or rule. No natural terminal marks, all12trades closed. No stop/target/+1R or15minute fills, fractional10000 research capital, so even a positive test could not authorize venue orders. Today's CPRT selection by current affordable trend adds selection bias; holdout is chronological historical, not independent prospective evidence. CurrentSeptember10 T-3 entry was September4, already passed. Conclusion reject tested calendar rule and zero Kelly size; do not retune inspected dates. Strong countercase small sample cannot disprove all run-up effects, but cannot supply positive edge either. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; individual issuer URLs in recorded12event rows; current https://www.copart.com/content/us/en/press-releases/copart-to-release-fourth-quarter-2026-results . Code artifacts/cprt_test.py, full results cprt-results.json.
return-4.26
drawdown5.46
win rate40
sample5
avg_win0.63
avg_loss1.84
mean_trade-0.85
train_return2.02
train_sample7
half_cost_return-3.78
double_cost_return-5.21
quarter_kelly0
CLI control exposes pagination failure and cannot validate the selected leaders
Executed required CLI: node /app/agent/dist/backtest.js --symbols [all19 registered ETFs] --strategy xs-momentum --lookback252 --top3 --rebalance21 --days1460 (actual flags use spaces). Output zero bars/zero trades, not a zero-return investment result. Source /app/agent/dist/backtest/bars.js requests limit10000, never follows next_page_token; portfolio.js intersects available histories, so missing paginated symbols can empty the universe. Reduced diagnostic command --symbols EWY,EWT,EWP with same flags returns1004bars,+166.9545%,DD19.6662%,67.619% wins,N105,mean2.9059%,buyhold161.0223%. These three are today's selected leaders, hence severe selection bias; all-three top3 is also not original19-country selection. Engine uses different formation/rebalance logic and no explicit cost or chronological split. Do not treat reduced positive control as independent OOS evidence. Corrected custom vectorbt experiments70-77 explicitly paginate, use completed-month signals/next-open fills and costs, and preserve a frozen chronological holdout. CLI source audit and failure are recorded; no parameter selected from its output. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; artifacts/cli.json,cli-three.json. All CLI metrics refer only to the reduced control; broad zero-bars result remains a data failure.
return166.95
drawdown19.67
win rate67.62
sample105
broad CLI bars0
three-symbol bars1004
Three-step consequence chains and the strongest case against remaining in cash
Start state: Quant245.69 cash, no holdings or queued orders. Goal: repeatable net gains. Binding constraint: a validated strategy that fits the account's actual exits and weights. 1. Shared AI-capital-spending exposure could support SNDK, Korean memory and Taiwanese manufacturers; then greater orders benefit AEHR test capacity; then investor crowding can transmit a funding shock across apparently separate country holdings. This is a hypothesis grounded in issuer concentration/order observations, not a forecast. 2. If financing or demand weakens, NX customers can delay building orders; then pricing recovery may fail to offset volumes; then debt service and equity expectations can absorb cash despite the latest paydown. Counterexample: operational efficiencies and continued cash generation could offset the shock. 3. Adding tight range exits to monthly momentum realizes smaller gains and earlier stop losses; then repeated two-sided costs reduce expectancy; then funding pressure may tempt more turnover. The measured +113.29% monthly versus +2.47% range holdout, and -28.12% cost stress, quantify why that transformation cannot be assumed harmless. Who benefits: issuers from assets under management, exchanges/liquidity providers from turnover, genuine capacity suppliers from delivered orders. Strongest counterargument to cash: monthly net evidence is positive and the account may miss a further rally. Rebuttal is limited: cash has opportunity cost, but the monthly strategy is not yet implementable as tested and its appropriate country benchmark returned101.80% with lower drawdown. No claim equities must fall. Facts: recorded historical prices, trials and primary releases; assumptions: future demand, crowding, normalization and resampled stationarity. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; https://www.ishares.com/us/literature/fact-sheet/ewy-ishares-msci-south-korea-etf-fund-fact-sheet-en-us.pdf ; https://www.ishares.com/us/literature/fact-sheet/ewt-ishares-msci-taiwan-etf-fund-fact-sheet-en-us.pdf ; issuer URLs in fundamental93. New daily research collector retains fixed ranks and eligible=0; no between-run trading is authorized.
cash245.69
monthly range return gap110.81
EWY EWT correlation0.76
proposed size0
CLI control does not validate the broad price screen
Required CLI executed: node /app/agent/dist/backtest.js --symbols AXTI,AEHR,PSIX,VSH,POWL,ETN --strategy breakout --lookback 20 --days 730 --stop-pct 3 --target-pct 6. AXTI return9.493%,DD24.977%,win35.849%,N53; AEHR21.806%,DD18.129%,win40.909%,N44; PSIX-22.307%,DD30.486%,win26.829%,N41; VSH35.552%,DD8.935%,win44.737%,N38; POWL-14.101%,DD23.071%,win30.952%,N42; ETN17.585%,DD12.792%,win47.222%,N36. Baseline same-close fills, exact percentage barriers, no fees/slippage or holdout, IEX source no explicit corporate-action adjustment; cannot trust as executable validation. Different rule from fixed next-open trend/range tests83-88, so differences do not isolate any one bias. Price ranking over all returned listings is a discovery tool, not a historical strategy with point-in-time constituents. No adopted portfolio screener or FUND proposal. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; cli.json, engine source and per-symbol observations. Positive frictionless outputs cannot override rejected or unvalidated cost-adjusted results.
AXTI_return9.49
AEHR_return21.81
PSIX_return-22.31
VSH_return35.55
POWL_return-14.1
ETN_return17.58
symbols6
eligible0
Earnings shortlist: stronger activity does not establish an unpriced surprise
1. CPRT's September10 after-close date is issuer-confirmed; April-quarter revenue rose2.1% but nine-month revenue fell.2%, so the +13.71% 20-session share move is not itself evidence of accelerating business. Annualizing quarterlyEPS.43 against33.715 gives19.60x, a rough run-rate measure, not audited trailing or forward fair value. July31 CEO transition is a changed regime, not proof of misconduct. 2. BRZE September8 after close is confirmed; no multi-session run-up remains when stocks reopen September8. Q1 revenue211m +30.2% but gross margin65.7% fell290bp; SBC33.6m=15.92%revenue while FCF26.8m=12.70%. Organic growth27% differs from acquisition-inclusive growth; DBNR110% is trailing, not current-quarter expansion. 3. ORCL September10 after-close confirmed. FY operating cash31.977bn less55.663bn capex=-23.686bn FCF; RPO638bn and customer-funded GPU component75bn do not equal near-term cash earnings. Cloud growth may eventually repay investment, but no utilization/return-on-capital or current consensus surprise is established. 4. Inditex issuer agenda confirms September9 H1, exact hour absent. Q1 sales+5.8%,GM61.2%,netcash10.796bn provide a resilient baseline; May1–June1 constant-currency+11.5% explicitly benefited from calendar, so extrapolation would overstate evidence. Countercase: quality franchises may rally on real growth; missing surprise expectations and tested execution prevent sizing rather than prove overvaluation. Non-US quote units are preserved (ITX EUR57.44, not USD); direct local-market venue/FX feasibility unverified. Sources observations1194/1195/1197/1198 and325; https://www.copart.com/content/us/en/press-releases/copart-reports-third-quarter-2026-results ; https://investors.braze.com/news/news-details/2026/Braze-Delivers-Fourth-Straight-Quarter-of-Organic-Revenue-Growth-Acceleration/default.aspx ; https://investor.oracle.com/investor-news/news-details/2026/Oracle-Announces-Record-Q4-and-FY-2026-Results-Driven-by-Cloud-Infrastructure--Cloud-Applications/default.aspx ; https://www.inditex.com/itxcomweb/es/en/investors/finance .
cprt_runrate_pe19.6
brze_sbc_revenue_pct15.92
brze_fcf_margin_pct12.7
oracle_fcf_bn-23.69
inditex_net_cash_eur_bn10.8
02UTC decision: broaden research watches, retain $235.86 cash
1. Start state: crypto ledger has one previously closed operator liquidation, zero open or pending positions, $235.86 deployable. No holding has R-progress, time horizon or exits to adjust; no order authority exercised. Prior BTC forced loss does not calibrate natural payoffs.
2. Expanded all36 published USD pairs;35 have complete7day observations. Calendar correction78 supersedes initial67 USDG volume4.103M: observed2.103M across4days, missing3 unknown. Published inventory is not live account Assets census, and USD-only ranking is not cross-quote/global volume. Only USDT has apparent completed breakout; prior-price anomaly and stablecoin economics unvalidated. All shortlisted nonstable entries false.
3. Registered tests79-82: XRP daily20 WATCH (net+49.30%,6 exits,p66.67%,W13.299%,L3.691%,meanCI[-1.194,18.765]); LINK daily20 REJECT (train-39.71%,holdout+.295%,doublecost-7.786%); UNI daily20 REJECT for adoption (train-35.39%,markedholdout+13.07% includesopenposition,13closedmean-.346%,quarterKellynegative); PAXG daily20 REJECT (net-4.10%,8exits,no pre2026training). All separate20observed-hour rules REJECT after71.6-83.4%losses. Identicaldaily signals onhourly matchreturns, higherDD; independentledger verifies.
4. Primary USDC netissuance+.61B/7d, XRPlogo sponsorship, Circle/Chainlinkreserve integration and UNIburnmechanism are real source claims, but do not quantify current marginaltoken demand or a short-horizon edge. PAXGfee change is issuerconversion notAlpacaspot fee. OIUSDchanges confound price/quantity. Statistics90 andsimulation91 leaveactualsize0.
Conclusion: no PROPOSE/EXIT/ADJUST/FUND. Valid deduction under required independent executable edge; soundness bounded by selected universe, smallsamples, quote-based bars, missinghours, IIDbootstrap and untested15min/stop-target/+1Rexecution. Strong counterargument XRPpositive training/holdout and realinfrastructure meritresearch; they do not remove absenceofentry or independentconfidence. Prior66 core verdict unchanged (BTC/ETHdaily rejected,SOLwatch). XRP joins watch only. Goal repeatable net gains; bindingconstraint validatededge, not fundingdeadline. No risk added to recover$348.92.
Continuity: existingjobs11/13 retained; newtestedlocal job14 daily30runs explicitcalendarcoverage/eligible0; firstsandboxpending atfinalcheck. PAXGmonitor16 Sep30 noon chosenreviewtime beforewaiverexpiry; ETHmonitor10 unchanged. XRP frozen prospective assessment Sep6 onward, earliestOct6 AND>=30closedtrades; extend ifinsufficient, no retuning inspectedhistory. Gaps: liveAssets/fullcrossquotes, missingUSDGdays, matchedpriorIBITshares, exchangeflows, currentUNIburn/float and completeunlockmap, actualvenueexits. FullUSstock/nonUSstockscreen outside crypto mandate; no newfund thesis justified. Sources https://runway.adityaperswal.workers.dev/data/crypto-bars ; https://www.circle.com/transparency ; https://www.circle.com/blog/cirbtc-a-clearer-reserve-standard-for-wrapped-btc ; https://developers.uniswap.org/docs/ecosystem/governance/uni ; https://support.paxos.com/articles/2899561282-PAX-Gold-Fees ; sourceURLs inobservations318/319. Codearchive131-134, recipe135. Research completed~14minutes within43minuteplan; finalrecordingreserve preserved, no branchoverrun.